Announcement of the Company’s full receipt of cash capital increase in 2025 and the record date of capital increase.

 

SEQ_NO  1 Date of announcement 2026/01/29 Time of announcement 15:47:19
Subject
Announcement of the Company's full receipt of cash
capital increase in 2025 and the record date of capital
increase.
Date of events 2026/01/29 To which item it meets paragraph 51
Statement
1.Date of occurrence of the event:2026/01/29
2.Company name:Excelsior Medical Co.,Ltd.
3.Relationship to the Company (please enter ”head office” or
”subsidiaries”):head office
4.Reciprocal shareholding ratios:Not applicable.
5.Cause of occurrence:According to Regulations Governing
the Offering and Issuance of Securities by Securities Issuers.
6.Countermeasures:None
7.Any other matters that need to be specified (the information disclosure
also meets the requirements of Article 7, subparagraph 9 of the Securities
and Exchange Act Enforcement Rules, which brings forth a significant impact
on shareholders rights or the price of the securities on public companies.):
(1)The company issued 16,800,000 new ordinary shares at NT$60 per share and
the aggregated amount was NT$1,008,000,000, which has been fully collected.
(2)The record date is set on January 29, 2026.
(3)The estimated listing date of new shares is February 3, 2026.